Sequential Therapies After Osteoanabolic Treatment

NCT06164795 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: Zoledronate
DRUG: Denosumab
DRUG: Teriparatide
DRUG: Romosozumab
DRUG: Abaloparatide Injection (80 mcg)

Sponsor

424 General Military Hospital